Injury Care Research & Family Care Research

What Injury Care Research & Family Care Research does

Injury Care Research & Family Care Research is a privately held, Phase II–IV clinical research site headquartered in Boise, Idaho, founded in 2008 by Jill Heinz, MHS, CCRP, CCRC. The organization operates as two linked divisions: Injury Care Research focuses on pain and musculoskeletal indications (low back pain, herniated discs, sciatica, osteoarthritis, gout, post-herpetic neuralgia), while Family Care Research, established in 2018, addresses chronic and metabolic conditions (ALS, asthma, cardiovascular disease, CIDP, diabetes, glaucoma, hyperlipidemia, hypertension, obesity, post-herpetic neuralgia). Study volunteers are seen at a single dedicated research clinic equipped with eSource and eRegulatory systems, five exam rooms, IV infusion capability, CLIA-waived labs, and temperature-controlled IP storage. The clinic is staffed by credentialed Principal Investigators and Sub-Investigators across pain management, physical medicine and rehabilitation, ophthalmology, dermatology, and family medicine, supported by certified clinical research coordinators, a regulatory specialist, and a recruitment specialist.

The business model is a professional services / site services model. Revenue is generated through per-study contracts with pharmaceutical and medical device sponsors who pay for patient enrollment, study procedures, data collection, and regulatory compliance; the company does not charge patients and provides care, study-related treatment, and compensation for time/travel to participants at no cost. Go-to-market is sales-led: the company engages sponsors directly (J&J, Pfizer, Purdue, Amgen, Eli Lilly, Celgene/BMS, Cidara) and recruits participants through a 10,000+ patient database, traditional media (TV, radio, print, online), community health fairs, alliances with local foundations, clinician referrals, and direct text/email outreach. Physician partners serve as Principal Investigators and Sub-Investigators and earn PI fees, functioning as both a recruitment channel and a referral pipeline for additional patient visits. Core technology consists of CRIO's eSource and Clinical Trial Management System for study documentation and payments, and Complion's eRegulatory Documentation system for IRB submissions and compliance — both deployed for sponsor-facing real-time data access and remote monitoring rather than as proprietary IP.

Name

Injury Care Research & Family Care Research

Legal name

Injury Care Research, LLC

Website

https://injurycareresearch.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

Injury Care Research & Family Care Research is a privately held Phase II–IV clinical trial site in Boise, Idaho, founded in 2008, conducting sponsor-paid research across pain, chronic metabolic, ophthalmologic, and dermatologic indications, serving pharmaceutical and medical device sponsors and study volunteers.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Health Care and Social Assistance (62)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

Keywords

• Clinical trial services
• Phase II-IV trials
• Clinical research site
• Patient recruitment services
• Pharmaceutical trial execution

Headquarters

HQ city

Boise

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial Site Services: The company operates as a clinical research site conducting Phase II-IV clinical trials on behalf of pharmaceutical and device company sponsors. Revenue is generated through per-study contracts with sponsors who pay for site services including patient enrollment, study procedures, data collection, and regulatory compliance. Since 2008, the company has been assisting pharmaceutical and device companies find new therapies to help patients better manage injuries and chronic disease.
2. Physician Partnership Fees: Benefits to physicians include increased income through Principal Investigator fees and additional patient visits. The company assumes up-front risk and minimizes physician time requirements, while providing flexibility to see patients at their facility or the research site.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Injury Care Research & Family Care Research operates a dedicated clinical research site in Boise, Idaho, conducting Phase II-IV clinical trials on behalf of pharmaceutical and device company sponsors. The two divisions cover pain, orthopedic, and neurological pain conditions (Injury Care Research) plus chronic and metabolic conditions including diabetes, cardiovascular disease, glaucoma, and respiratory disorders (Family Care Research). Services include patient enrollment, study procedures, regulatory compliance, data collection, and accounting for sponsors, with a 10,000+ patient recruitment database and physician partner network.

Product overview

Injury Care Research & Family Care Research operates as a unified clinical research organization offering Phase II-IV clinical trial services through two specialized divisions. Injury Care Research focuses on pain-related therapeutic areas including musculoskeletal conditions (back pain, osteoarthritis, gout) and neurological pain (sciatica, post-herpetic neuralgia). Family Care Research addresses chronic metabolic and systemic conditions including diabetes, cardiovascular disease, glaucoma, and respiratory disorders. The company utilizes CRIO's eSource and Clinical Trial Management Software for study documentation and payment processing, and Complion's eRegulatory Documentation software for regulatory submissions. Study volunteers receive care at the company's dedicated research clinic in Boise, Idaho.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Research Services (Phase II-IV) Phase II-IV clinical trial services conducted across multiple therapeutic areas including pain management, orthopedics, ophthalmology, dermatology, and chronic disease, delivered from the company's dedicated Boise, Idaho research clinic for pharmaceutical and device company sponsors. Services include patient enrollment, study procedures, data collection, regulatory compliance, contracts/budgets, and accounting.
• Injury Care Research Specialized clinical research division focusing on pain-related conditions including chronic and acute low back pain, herniated discs, lumbosacral radicular pain (sciatica), osteoarthritis (ankle, knee, shoulder), gout, and post-herpetic neuralgia for pharmaceutical and device sponsors.
• Family Care Research Clinical research division focusing on chronic and metabolic conditions including ALS, asthma, cardiovascular disease, CIDP, diabetes, glaucoma, hyperlipidemia, hypertension, obesity, and post-herpetic neuralgia for pharmaceutical and device sponsors.

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• Exodus Pain CliniccoreStrategic or Co-development PartnerDr. Daniel Marsh owns Exodus Pain Clinic and partners with Injury Care Research to provide excellent care for research patients. Dr. Marsh is fellowship-trained and board-certified in Physical Medicine and Rehabilitation as well as Pain Management subspecialty. He performs multiple interventional medicine techniques including TESIs, ESIs, Medial Branch Blocks, Lumbar Radiofrequency Ablation, SI joint injections, and peripheral joint injections. He serves as a Sub-investigator on clinical trial protocols.
• Intermountain Eye CenterscoreStrategic or Co-development PartnerDr. Adam Reynolds practices at Intermountain Eye Centers and serves as Principal Investigator for glaucoma-related clinical trials at Injury Care Research. He completed a fellowship in glaucoma at McGee Eye Institute and specializes in advanced diagnostic and treatment modalities for glaucoma, including advanced non-invasive glaucoma laser and surgical interventions.
• Johnson & JohnsonminorOthersPharmaceutical sponsor for which Dr. Radnovich has served as principal investigator on research projects testing new treatments for conditions like back pain, shingles, and arthritis.
• PfizerminorOthersPharmaceutical sponsor for which Dr. Radnovich has served as principal investigator on research projects testing new treatments for conditions like back pain, shingles, and arthritis.
• Purdue PharmaminorOthersPharmaceutical sponsor for which Dr. Radnovich has served as principal investigator on research projects testing new treatments for conditions like back pain, shingles, and arthritis.
• AmgenminorOthersPharmaceutical sponsor for which David Narouz has led and supported studies. Amgen is one of the world's largest biotechnology companies.
• Eli LillyminorOthersPharmaceutical sponsor for which David Narouz has led and supported studies.
• CelgeneminorOthersPharmaceutical sponsor (now part of Bristol-Myers Squibb) for which David Narouz has led and supported studies focusing on immunology and chronic disease research.
• Cidara TherapeuticsminorOthersBiotechnology sponsor for which David Narouz has led and supported studies.
• CRIOcoreTechnology or IntegrationSoftware provider for eSource documentation and Clinical Trial Management. CRIO's eSource software enables real-time data access for sponsors/CROs and remote monitoring. Their CTMS manages all study payments from sponsors to vendors, physicians, and subjects.
• ComplioncoreTechnology or IntegrationSoftware provider for eRegulatory Documentation. Complion's state-of-the-art system is used for administering all regulatory procedures including IRB submissions, protocol training documentation, and ongoing regulatory maintenance.
• Local Foundations & Healthcare OrganizationsminorChannel Partner/ Reseller/ DistributorAlliances with various local foundations and clinician referrals support the company's recruitment efforts and community engagement.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• PMG Research: PMG Research is an independent clinical research site network partnering with large healthcare systems and community physicians to conduct Phase II–IV trials — directly comparable in site-based trial delivery, physician investigator partnerships, and pharma-sponsor revenue model.
• Accel Research Sites: Accel Research Sites is an independent multi-site clinical research organization operating dedicated research clinics across the U.S., running Phase II–IV trials for pharmaceutical and device sponsors — directly comparable to Injury Care Research's site-network model and multi-therapeutic positioning.
• Avania Clinical Research: Avania is a clinical research organization providing site management and CRO services to medical device and pharmaceutical sponsors across multiple therapeutic areas — directly comparable in Phase II–IV trial delivery, multi-therapeutic scope, and sponsor-funded services.
• Wake Research: Wake Research is an independent multi-therapeutic clinical research site network headquartered in the U.S. that conducts Phase II–IV trials for pharma and device sponsors — directly comparable in clinical research site operations, multi-therapeutic scope, and sponsor-funded business model.
• Meridian Clinical Research: Meridian Clinical Research operates a network of independent clinical research sites across the U.S. enrolling patients in Phase II–IV trials — directly comparable to Injury Care Research's site-based model, sponsor relationships, and multi-specialty therapeutic focus.
• Benchmark Research: Benchmark Research is an independent clinical research site operating in the U.S. that conducts Phase II–IV trials for pharmaceutical and device sponsors — directly comparable in independent-site business model, multi-therapeutic positioning, and sponsor-contract revenue structure.
• Velocity Clinical Research: Velocity Clinical Research operates one of the largest integrated clinical research site networks in the United States, conducting Phase II–IV trials across multiple therapeutic areas for pharma and biotech sponsors — directly comparable to Injury Care Research's site-based, sponsor-funded trial execution model, with substantially greater geographic reach.

Broad incumbents

• Medpace: Medpace is a large global CRO providing full-service clinical development including site management and monitoring for pharmaceutical and device sponsors — a broader incumbent operating in the same end-market of Phase II–IV clinical trial delivery, with overlapping sponsor relationships but a much wider portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/IFCR_Boise
• Facebookfacebook.com/InjuryCareFamilyCareResearch
• LinkedInlinkedin.com/company/injury-care-research

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Injury Care Research & Family Care Research